ENTERIC COATED (EC)

PRODUCT NAME	TYPE	COMPOSITION	Therapeutic Usage
Esomeprazole	EC	8.5% & 22.5%w/w	Gastroesophageal reflux disease
Lansoprazole	EC	8.5%,12.5%%w/w	Gastroesophageal reflux disease
Omeprazole	EC	7.0%, 7.5%, 8.5% w/w	Gastroesophageal reflux disease
Pantoprazole	EC	15%, 20%,22% & 22.5%,w/w	Gastroesophageal reflux disease
Dexlansoprazole	DDR (Dual Delayed Release)	22.5 %w/w	Gastroesophageal reflux disease
Esomeprazole	MUPS	11%w/w, 22% w/w & 22.5 %w/w	Gastroesophageal reflux disease
Lansoprazole	MUPS	11%w/w	Gastroesophageal reflux disease
Rabeprazole	EC	.5%, 8.5%, 10%, 12.5%, 13.2%, 20%, 11.9% &13%	Gastroesophageal reflux disease
Roxithromycin EC	EC	54.5% w/w	Anti-Infective

IMMEDIATE RELEASE (IR)

PRODUCT NAME	TYPE	COMPOSITION	Therapeutic Usage
Aprepitant	IR	40% w/w	Anti-Emetic
Ambroxol	IR	28% & 40% w/w	Respiratory
Azithromycin Pellets Test Mask Granules.	IR	5.5%,25% and 40 w/w %	Anti Biotic
Ciprofloxacin Test mask Pellets.	IR	20% w/w	Anti Biotic
Domperidone	IR	10% & 20% w/w	Anti-Emetic
Fluconazole	IR	40% w/w	Anti-fungal
Itraconazole	IR	20%, 22% w/w	Anti-fungal
Itraconazole (BP)	IR	20%, 22% w/w	Anti-fungal
Dabigatran	IR	35% & 40 % w/w	Anti-coagulant
Itraconazole (BP)	IR	20%, 22% w/w	Anti-fungal
Nifedipine	IR	10% & 11% w/w	Cardio Vascular

SUSTAIN RELEASE (SR)

PRODUCT NAME	TYPE	COMPOSITION	Therapeutic Usage
Aceclofenac	SR	60% w/w	Anti-Inflammatory
Diclofenac Sodium	SR	40% w/w	NSAID
Domperidone	SR	20%, 30% w/w	Anti-Emetic agent
Itopride HCL	SR	60% w/w	Prokinetic agent and used in traetment of Dyspepsia
Levosulpiride	SR	50% w/w	Anti-psychotic
Flurbiprofen	SR	60% w/w	NSAID
Ketoprofen	SR	60% w/w,70%w/w	NSAID
Nimesulide	SR	33.3% W/W	Anti-Inflammatory
Tamsulosin HCl	SR	0.20% w/w & 0.16% w/w	Benign Prostatic hyperplasia
Mebeverine	SR	80% w/w	Anti-Spasmodic